AUSTIN, Texas — On Friday, Oct. 10, 2014, the Texas Institute for Robotic Surgery at St. David’s North Austin Medical Center was the first facility in Texas, and among the first in the nation, to perform procedures using the new Single-Site® Wristed Needle Driver for use with the da Vinci® Si® Surgical System.
The Single-Site Wristed Needle Driver—the first fully articulating robotic single-port instrument for use in single-incision surgeries—provides surgical precision, control, stability and an ergonomic seated position, as well as three-dimensional, high-definition visualization. Together, the da Vinci System and Single-Site instruments are designed to minimize crowding of instruments during surgery while optimizing available surgical space, as compared with hand-held, laparoscopic single-incision instrumentation.
The instrument is used for minimally invasive removal of the uterus (hysterectomy), the ovaries and fallopian tubes for benign conditions, as well as the removal of the gallbladder.
“The new Single-Site Wristed Needle Driver completes the evolution of the Single-Site platform,” Thomas Payne, M.D., medical director of the Texas Institute for Robotic Surgery, said. “We are pleased to continue to be at the forefront of robotic surgery, offering advanced technology to patients seeking minimally invasive options.”
Devin Garza, M.D., a surgeon with the Texas Institute for Robotic Surgery and Renaissance Women’s Group, performed the first surgery—a hysterectomy—using the advanced, FDA-approved instrument.
The Texas Institute for Robotic Surgery was launched in March 2011. It houses the world’s largest collective intelligence on robotic surgery, bringing together information on quality, performance and cost from nearly 100 hospitals across the United States.
The Texas Institute for Robotic Surgery is an international treatment, training and research center that combines excellence in robotic-assisted surgery and outcomes with education and training, featuring an educational epicenter teaching best practices to hospital leadership, surgeons and surgical teams involved in the delivery of robotic-assisted da Vinci surgery.